Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis.

This study demonstrated that Black IPF patients had lower antifibrotic use compared to White, Hispanic and Asian patients. Our findings suggest that urgent action is needed to understand the reason why racial disparities exist in the treatment of IPF.